<?xml version='1.0' encoding='UTF-8'?>
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="publisher-id">Nature and Science of Sleep</journal-id>
      <journal-title-group>
        <journal-title>Nature and Science of Sleep</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1179-1608</issn>
      <publisher>
        <publisher-name>Dove Medical Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">30323695</article-id>
      <article-id pub-id-type="pmc">6179580</article-id>
      <article-id pub-id-type="doi">10.2147/NSS.S179670</article-id>
      <article-id pub-id-type="publisher-id">nss-10-313</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Comment on: use of blood biomarkers to screen for obstructive sleep apnea</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Abrams</surname>
            <given-names>Burton</given-names>
          </name>
          <xref ref-type="aff" rid="af1-nss-10-313"/>
          <xref ref-type="corresp" rid="c1-nss-10-313"/>
        </contrib>
      </contrib-group>
      <aff id="af1-nss-10-313">Zeger-Abrams Inc., Elkins Park, PA, USA, <email>burtabrams@hotmail.com</email></aff>
      <author-notes>
        <corresp id="c1-nss-10-313">Correspondence: Burton Abrams, 221 Linden Drive, Elkins Park, PA 19027, USA, Email <email>burtabrams@hotmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2018</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>04</day>
        <month>10</month>
        <year>2018</year>
      </pub-date>
      <volume>10</volume>
      <fpage>313</fpage>
      <lpage>315</lpage>
      <permissions>
        <copyright-statement>© 2018 Abrams. This work is published and licensed by Dove Medical Press Limited</copyright-statement>
        <copyright-year>2018</copyright-year>
        <license>
          <license-p>The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.</license-p>
        </license>
      </permissions>
      <related-article related-article-type="commentary-article" id="RA1" vol="10" page="159" xlink:href="29942168" ext-link-type="pubmed">159–167</related-article>
    </article-meta>
  </front>
  <body>
    <p><citation_analysis attribute="positive">
      </citation_analysis><citation_analysis attribute="positive"><bold>Dear editor</bold></citation_analysis><citation_analysis attribute="positive">
    </citation_analysis></p>
    <p><citation_analysis attribute="neither">The recently published paper in </citation_analysis><citation_analysis attribute="positive"><italic>Nature and Science of Sleep</italic></citation_analysis><citation_analysis attribute="positive"><xref rid="b1-nss-10-313" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="positive"> describes a combination of blood biomarkers for obstructive sleep apnea (OSA) screening which is shown to have better sensitivity and selectivity than any one individually. The combination comprises elevated levels of glycated hemoglobin (HbA1c), C-reactive protein, and erythropoeitin. The combination algorithm alluded to in the paper requires a sufficiently elevated level above a threshold of the combination of the three constituents for further diagnostic testing to be recommended. Of course, OSA would have to have been present long enough for the elevated levels to occur in order for the proposed biomarker to indicate its likely presence. My comment on this paper questions not whether this screening tool is valid, but whether it is valid early enough in the development of OSA to initiate diagnosis and treatment before some irreversible life-threatening consequence of OSA develops.</citation_analysis></p>
    <p><citation_analysis attribute="neither">In particular, I focus on HbA1c, which when elevated above 5.7% indicates prediabetes or diabetes, a recognized common consequence of OSA which risks the quality and length of life. The meta-analyses in</citation_analysis><citation_analysis attribute="positive"><xref rid="b2-nss-10-313" ref-type="bibr">2</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b3-nss-10-313" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="negative"> conclude that overcoming OSA does not generally reduce HbA1c, although it may improve insulin sensitivity. Insulin insufficiency from beta cell dysfunction and mass reduction remains to keep HbA1c elevated, and diabetes is still a threat.</citation_analysis></p>
    <p><citation_analysis attribute="neither">There is another biomarker, although not a blood biomarker, which appears earlier in the development of OSA. It is the formation of monosodium urate crystals on patellar, biceps, or quadriceps tendons, where they are detectable by ultrasonic means.</citation_analysis><citation_analysis attribute="positive"><xref rid="b4-nss-10-313" ref-type="bibr">4</xref></citation_analysis><citation_analysis attribute="positive"> The intermittent hypoxemia which results from OSA causes three effects which quickly elevate the concentration of serum uric acid, often leading to the precipitation of mono-sodium urate crystals: 1) intermittent cell catabolism which culminates irreversibly in the generation of excess uric acid fed into the blood; 2) concurrent intermittent serum acidosis and hypercapnia which reduces the solubility of uric acid in the blood; and 3) gradual reduction of the kidneys’ glomerular filtration rate which slows removal of serum uric acid. Once formed, the crystals dissolve very slowly, which allows for their detection at any time convenient for OSA screening.</citation_analysis></p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="COI-statement">
        <p><citation_analysis attribute="positive">
          </citation_analysis><citation_analysis attribute="positive"><bold>Disclosure</bold></citation_analysis><citation_analysis attribute="positive">
        </citation_analysis></p>
        <p><citation_analysis attribute="neither">The author reports no conflicts of interest in this communication.</citation_analysis></p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="b1-nss-10-313">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fleming</surname>
              <given-names>WE</given-names>
            </name>
            <name>
              <surname>Holty</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Bogan</surname>
              <given-names>RK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Use of blood biomarkers to screen for obstructive sleep apnea</article-title>
          <source>Nat Sci Sleep</source>
          <year>2018</year>
          <volume>10</volume>
          <fpage>159</fpage>
          <lpage>167</lpage>
          <pub-id pub-id-type="pmid">29942168</pub-id>
        </element-citation>
      </ref>
      <ref id="b2-nss-10-313">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Feng</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Dong</surname>
              <given-names>ZZ</given-names>
            </name>
          </person-group>
          <article-title>Effects of continuous positive airway pressure therapy on glycaemic control, insulin sensitivity and body mass index in patients with obstructive sleep apnoea and type 2 diabetes: a systematic review and meta-analysis</article-title>
          <source>NPJ Prim Care Respir Med</source>
          <year>2015</year>
          <volume>25</volume>
          <fpage>15005</fpage>
          <pub-id pub-id-type="pmid">25719929</pub-id>
        </element-citation>
      </ref>
      <ref id="b3-nss-10-313">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Labarca</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Reyes</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Jorquera</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>CPAP in patients with obstructive sleep apnea and type 2 diabetes mellitus: systematic review and meta-analysis</article-title>
          <source>Clin Respir J</source>
          <year>2018</year>
          <comment>In press</comment>
        </element-citation>
      </ref>
      <ref id="b4-nss-10-313">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abrams</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Monosodium urate as a biomarker for obstructive sleep apnea</article-title>
          <source>J Sleep Disord: Treat Care</source>
          <year>2017</year>
          <volume>6</volume>
          <issue>2</issue>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article id="sa1" article-type="reply">
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">Nat Sci Sleep</journal-id>
        <journal-id journal-id-type="iso-abbrev">Nat Sci Sleep</journal-id>
        <journal-id journal-id-type="publisher-id">Nature and Science of Sleep</journal-id>
        <journal-title-group>
          <journal-title>Nature and Science of Sleep</journal-title>
        </journal-title-group>
        <issn pub-type="epub">1179-1608</issn>
        <publisher>
          <publisher-name>Dove Medical Press</publisher-name>
        </publisher>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="publisher-id">nss-10-313</article-id>
        <article-categories>
          <subj-group subj-group-type="heading">
            <subject>Letter</subject>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>Authors’ reply</article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author">
            <name>
              <surname>Fleming</surname>
              <given-names>Wesley Elon</given-names>
            </name>
            <xref ref-type="aff" rid="af2-nss-10-313">1</xref>
            <xref ref-type="corresp" rid="c2-nss-10-313"/>
          </contrib>
          <contrib contrib-type="author">
            <name>
              <surname>Holty</surname>
              <given-names>Jon-Erik C</given-names>
            </name>
            <xref ref-type="aff" rid="af3-nss-10-313">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name>
              <surname>Bogan</surname>
              <given-names>Richard K</given-names>
            </name>
            <xref ref-type="aff" rid="af4-nss-10-313">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name>
              <surname>Hwang</surname>
              <given-names>Dennis</given-names>
            </name>
            <xref ref-type="aff" rid="af5-nss-10-313">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name>
              <surname>Ferouz-Colborn</surname>
              <given-names>Aliya S</given-names>
            </name>
            <xref ref-type="aff" rid="af5-nss-10-313">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name>
              <surname>Budhiraja</surname>
              <given-names>Rohit</given-names>
            </name>
            <xref ref-type="aff" rid="af6-nss-10-313">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <name>
              <surname>Redline</surname>
              <given-names>Susan</given-names>
            </name>
            <xref ref-type="aff" rid="af6-nss-10-313">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <name>
              <surname>Mensah-Osman</surname>
              <given-names>Edith</given-names>
            </name>
            <xref ref-type="aff" rid="af7-nss-10-313">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name>
              <surname>Osman</surname>
              <given-names>Nadir Ishag</given-names>
            </name>
            <xref ref-type="aff" rid="af7-nss-10-313">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name>
              <surname>Li</surname>
              <given-names>Qing</given-names>
            </name>
            <xref ref-type="aff" rid="af8-nss-10-313">7</xref>
          </contrib>
          <contrib contrib-type="author">
            <name>
              <surname>Azad</surname>
              <given-names>Armaghan</given-names>
            </name>
            <xref ref-type="aff" rid="af2-nss-10-313">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name>
              <surname>Podolak</surname>
              <given-names>Susann</given-names>
            </name>
            <xref ref-type="aff" rid="af2-nss-10-313">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name>
              <surname>Samoszuk</surname>
              <given-names>Michael K</given-names>
            </name>
            <xref ref-type="aff" rid="af9-nss-10-313">8</xref>
          </contrib>
          <contrib contrib-type="author">
            <name>
              <surname>Cruz</surname>
              <given-names>Amabelle B</given-names>
            </name>
            <xref ref-type="aff" rid="af9-nss-10-313">8</xref>
          </contrib>
          <contrib contrib-type="author">
            <name>
              <surname>Bai</surname>
              <given-names>Yang</given-names>
            </name>
            <xref ref-type="aff" rid="af9-nss-10-313">8</xref>
          </contrib>
          <contrib contrib-type="author">
            <name>
              <surname>Lu</surname>
              <given-names>Jiuliu</given-names>
            </name>
            <xref ref-type="aff" rid="af9-nss-10-313">8</xref>
          </contrib>
          <contrib contrib-type="author">
            <name>
              <surname>Riley</surname>
              <given-names>John S</given-names>
            </name>
            <xref ref-type="aff" rid="af9-nss-10-313">8</xref>
          </contrib>
          <contrib contrib-type="author">
            <name>
              <surname>Southwick</surname>
              <given-names>Paula C</given-names>
            </name>
            <xref ref-type="aff" rid="af9-nss-10-313">8</xref>
          </contrib>
        </contrib-group>
        <aff id="af2-nss-10-313">
<label>1</label>Sleep Center Orange County, Irvine, CA, USA, <email>flemingwesley@gmail.com</email></aff>
        <aff id="af3-nss-10-313">
<label>2</label>Stanford Medical School, VA Palo Alto Health Care System, Pulmonary, Critical Care and Sleep Medicine Section, Palo Alto, CA, USA</aff>
        <aff id="af4-nss-10-313">
<label>3</label>SleepMed Inc., Bogan Sleep Consultants, LLC, Columbia, SC, USA</aff>
        <aff id="af5-nss-10-313">
<label>4</label>Sleep Medicine Department, Southern California Permanente Medical Group, Kaiser Permanente, Fontana Medical Center, Fontana, CA, USA</aff>
        <aff id="af6-nss-10-313">
<label>5</label>Division of Sleep Medicine, Harvard Medical School, Brigham and Women’s Hospital, Boston, MA, USA</aff>
        <aff id="af7-nss-10-313">
<label>6</label>EENA Comprehensive Neurology and Sleep Center, Boynton Beach, FL, USA</aff>
        <aff id="af8-nss-10-313">
<label>7</label>South Bend Medical Foundation, New Technology and Test Development, South Bend, IN, USA</aff>
        <aff id="af9-nss-10-313">
<label>8</label>Clinical Research Department, Beckman Coulter, Inc., Brea, CA, USA</aff>
        <author-notes>
          <corresp id="c2-nss-10-313">Correspondence: Wesley Elon Fleming, Sleep Center Orange County, 4980 Barranca Pkwy, Ste 170, Irvine, CA 92604, USA, Tel +1 949 679 5510, Fax +1 949 679 1080, Email <email>flemingwesley@gmail.com</email></corresp>
        </author-notes>
        <pub-date pub-type="collection">
          <year>2018</year>
        </pub-date>
        <pub-date pub-type="epub">
          <day>04</day>
          <month>10</month>
          <year>2018</year>
        </pub-date>
        <volume>10</volume>
        <fpage>315</fpage>
        <lpage>315</lpage>
        <permissions>
          <copyright-statement>© 2018 Abrams. This work is published and licensed by Dove Medical Press Limited</copyright-statement>
          <copyright-year>2018</copyright-year>
          <license>
            <license-p>The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.</license-p>
          </license>
        </permissions>
      </article-meta>
    </front>
    <body>
      <p><citation_analysis attribute="positive">
        </citation_analysis><citation_analysis attribute="positive"><bold>Dear editor</bold></citation_analysis><citation_analysis attribute="positive">
      </citation_analysis></p>
      <p><citation_analysis attribute="neither">We would like to thank Burton Abrams, MS, for the letter in response to our recently published article.</citation_analysis></p>
      <p><citation_analysis attribute="neither">Mr Abrams questions whether our new screening tool is valid early enough in the development of OSA to initiate diagnosis and treatment before irreversible life-threatening consequences of OSA develop. We would like to reiterate that the algorithm score derived from a combination of three biomarkers correlated with severity of disease (none, mild, moderate, severe), allowing sleep centers to identify and triage lower- to higher-risk patients for sleep study testing and treatment. In addition, the combination of biomarkers performed significantly better than current screening methods. Given that up to 90% of individuals with obstructive sleep apnea (OSA) remain undiagnosed and untreated, this new screening tool represents a substantial improvement in early identification of OSA.</citation_analysis></p>
      <p><citation_analysis attribute="neither">Mr Abrams’ work on ultrasonic detection of monosodium urate is interesting, and we commend any effort to improve upon the early detection of OSA.</citation_analysis></p>
    </body>
    <back>
      <ack>
        <title>Acknowledgments</title>
        <p><citation_analysis attribute="neither">This work was supported by research grant funding from Beckman Coulter, Inc. (Brea, CA, USA) provided to the respective institutions of Drs Fleming, Holty, Bogan, Hwang, Ferouz-Colborn, Budhiraja, Redline, Mensah-Osman, Osman, and Li.</citation_analysis></p>
      </ack>
      <fn-group>
        <fn fn-type="COI-statement">
          <p><citation_analysis attribute="positive">
            </citation_analysis><citation_analysis attribute="positive"><bold>Disclosure</bold></citation_analysis><citation_analysis attribute="positive">
          </citation_analysis></p>
          <p><citation_analysis attribute="neither">Drs Samoszuk, Riley, and Southwick, as well as Ms Cruz, Mr Bai, and Mr Lu are employed by Beckman Coulter. The authors report no other conflicts of interest in this communication.</citation_analysis></p>
        </fn>
      </fn-group>
    </back>
  </sub-article>
</article>
</pmc-articleset>
